House lawmakers revive bipartisan forecasting bill
The 'Weather Act Reauthorization bill,' H.R. 3816, would 'fund ongoing critical research programs while also establishing new programs to advance forecasting, expand commercial data partnerships, strengthen emergency preparedness, and advance tools for farmers, ranchers and resource managers,' according to a release from sponsor Rep. Frank Lucas.
The Oklahoma Republican used to chair the Science, Space and Technology Committee. The panel's current ranking member, Rep. Zoe Lofgren (D-Calif.), is the bill's main co-sponsor.
Advertisement
The legislation would fund the modernization of weather research programs, including for tornado warning and hurricane forecasting technologies. And it would increase NOAA's access to forecasting data by expanding its authority to contract with the private sector.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
27 minutes ago
- CBS News
Heavy rain Wednesday could cause flooding in Tri-State Area. Get the First Alert Weather Day forecast.
Heavy rain could lead to flooding in parts of the Tri-State Area on Wednesday and Thursday, triggering First Alert Weather Days. While weather conditions have been pretty quiet to begin the week, they're going to become much more active in the short term. Tuesday night, clouds will start to increase, a few sprinkles and/or light showers may develop towards dawn. Lows will mainly be in the low to mid 60s. The chance of rain then increases exponentially throughout the day on Wednesday. The morning hours will feature isolated light showers and maybe some drizzle, but by the afternoon, heavy rain will already be ongoing across the northern suburbs. That heavy rain becomes more widespread and more intense by the evening hours, continuing through the overnight hours of Wednesday into early Thursday morning. Rainfall rates could approach 1 inch per hour at times, therefore the risk of flash flooding is imminent. Temperature-wise, another below average day is expected on Wednesday, with highs only in the low 70s. After a wet early morning, the rain tapers off by late morning on Thursday. Final rainfall totals will average 1-2 inches, with some locally higher amounts possible. As the rain ends, Hurricane Erin will be between 350-450 miles offshore. While no direct impacts are likely, indirect impacts are highly likely. These effects will come in the form of dangerous rip currents, very high surf that could reach as high as 15 feet in some locations, and coastal flooding that could result in 1-2 feet of inundation. Gusty winds will also be an issue at the coast, gusting between 35-50 mph. Those winds, in conjunction with saturated soils from the heavy rain, may lead to downed trees and power lines. The main timeframe of Erin's coastal impacts will be throughout the day on Thursday and could linger into Friday. High Surf Advisory for all beaches in New Jersey, New York City and the south shore of Long Island from Wednesday into Thursday. Coastal Flood Watch for Monmouth and Ocean counties from Thursday into Friday. Jersey Shore: Windy conditions, gusting between 35-45 mph, very high surf, dangerous rip currents, coastal flooding, and beach erosion. Waves 8-13 feet. Long Island: Windy conditions, gusting between 35-50 mph. Very high surf, dangerous rip currents, coastal flooding, and beach erosion. Waves 10-15 feet. NYC: Breezy conditions, gusting between 20-40 mph. City beaches will see very high surf, dangerous rip currents, coastal flooding, and beach erosion. Waves 8-13 feet. Hudson Valley, Northern & Central New Jersey, Connecticut: Not much effects in these areas other than some clouds and gusty winds, gusting between 25-35 mph.
Digital Trends
28 minutes ago
- Digital Trends
NASA and Google are testing an AI space doctor
With NASA eyeing long-duration crewed missions to the moon and beyond in the coming years, it has to be sure that if a medical situation arises, the astronauts are well equipped to deal with it. Currently, crews heading to the International Space Station (ISS) receive training for basic medical procedures and medicines, as well as for things like intravenous fluid administration, intubation, wound care, and basic emergency response. Recommended Videos But future missions that take humans hundreds of thousands — or even millions — of miles from Earth, potentially for years at a time, will add a new layer of complexity to health management. With that in mind, the U.S. space agency has partnered with Google on a project aimed at ensuring crew health and wellness on long-duration missions. The initiative includes an investigation into whether remote care capabilities can offer detailed diagnoses and treatment options when a health issue falls outside of the astronauts' knowledge base, and when real-time communication with Earth is limited. NASA and Google's work involves a proof-of-concept for an automated Clinical Decision Support System (CDSS) known as the 'Crew Medical Officer Digital Assistant' (CMO-DA). 'Designed to assist astronauts with medical help during extended space missions, this multi-modal interface leverages AI,' Google said in an online post. It said the CMO-DA tool could help astronauts 'autonomously diagnose and treat symptoms when crews are not in direct contact with Earth-based medical experts.' It added: 'Trained on spaceflight literature, the AI system uses cutting-edge natural language processing and machine learning techniques to safely provide real-time analyses of crew health and performance. The tool is designed to support a designated crew medical officer or flight surgeon in maintaining crew health and making medical decisions driven by data and predictive analytics.' Early results from initial trials have 'showed promise' for obtaining reliable diagnoses based on reported symptoms. Moving forward, NASA and Google are now working with medical doctors to improve the technology with a view to using it on future space missions. As part of NASA's Artemis program, astronauts could one stay for extended periods aboard a lunar satellite — similar to how they live and work aboard the ISS today — or even on the moon itself. More ambitious endeavors, such as to Mars, are also on the cards, but aren't expected to take place until the 2030s at the earliest.
Yahoo
an hour ago
- Yahoo
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
CAMBRIDGE, Mass., Aug. 19, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases. This collaboration will be based on XtalPi's intelligent and automated drug discovery platform, which integrates artificial intelligence (AI), quantum physics, and large-scale automated robotic experiments. The two companies plan to co-identify targets and discover first-in-class or best-in-class drug candidates using XtalPi's proprietary AI-driven drug discovery platform. The XtalPi platform combines the speed and generative power of AI with the accuracy of its robotic lab-in-the-loop to accelerate drug discovery and vastly expand the explorable chemical space. This integrated workflow spans deep-learning-based molecule design, quantum physics and molecular dynamics simulations for predicting drug-target interactions, automated chemical synthesis, and experimental validation of candidate compounds' key pharmaceutical properties. Leveraging its expertise in immunology and inflammation as well as its experience in small molecule drug development, Dong-A ST will actively participate throughout the entire R&D process—including candidate validation, efficacy and safety testing, and the formulation of preclinical and clinical development strategies. The company also plans to explore strategies for pipeline expansion and assess commercialization potential. Through this partnership, Dong-A ST aims to strengthen its pipeline in the immunology and inflammation space and expand its R&D scope beyond small molecule therapeutics into areas such as targeted protein degradation (TPD), biologics, antibody-drug conjugates (ADC), and gene therapies. John Wang, Senior Vice President of Drug Discovery at XtalPi, stated: "The combination of Dong-A ST's extensive expertise and XtalPi's proven AI-robotics platform is well-positioned to translate scientific innovation into competitive precision medicines. Together, we aim to rapidly discover and rigorously validate novel drug candidates across multiple modalities to unlock unique market opportunities, and deliver transformative therapies for global patients." Jae-Hong Park, Head of R&D at Dong-A ST, remarked, "This collaboration marks a pivotal step in expanding Dong-A ST's R&D capabilities," adding, "By leveraging synergies with XtalPi's AI platform, we expect to accelerate the development of next-generation treatments for immune and inflammatory diseases." Meanwhile, both Dong-A ST and XtalPi operate open innovation offices in Boston, USA. This geographic proximity will facilitate closer and more efficient collaboration throughout the drug discovery process. About Dong-A ST Dong-A ST Co., Ltd. ( was established in 1932 and is a leading Korean pharmaceutical company engaged in the development, manufacturing, and commercialization of ethical drugs, biosimilars, medical devices, and diagnostics. Its key products include Stillen (gastritis), Zydena (erectile dysfunction), Motilitone (functional dyspepsia), and Imuldosa (ustekinuma biosimilar). Leveraging strong R&D capabilities and a history of innovation, Dong-A ST is expanding its pipeline in immunology, inflammation, neurological disease, metabolic diseases, and oncology, while advancing into new modalities such as biologics, ADCs, TPD, and gene therapies. About XtalPi XtalPi Holdings Limited (XtalPi, was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries. View original content to download multimedia: SOURCE XtalPi Inc. Sign in to access your portfolio
